Concussions and TBI

Concussions/ mild TBIs are injuries of the brain that result in a harmful metabolic cascade of events within the neural tissue. These injuries are due to direct contact or abrupt force that leads to the brain hitting the inside of the skull. The harmful events that take place at the cellular level include ionic flux, energy crisis, cytoskeletal damage, and axonal dysfunction. Although there are a lot of things happening in the brain following an injury, they are not easy to detect with normal imaging and procedures and each case is unique. Because of this, proper treatment and periods of rest can be hard to gauge.

Pathophysiology

After an injury, an ionic flux happens within the brain. This means that the ion channels are not working to maintain a proper membrane potential within neural cells. A spread of inhibition is produced from the site of injury referred to as “spreading depression.”  In an effort to reinstate homeostasis, ion channels that require energy become overworked. Intracellular energy is depleted, cells enter hyper glycolysis, and the brain shifts into an energy crisis. Neural cells use energy up before more ATP can be synthesized. Free radicals are produced, and metabolic pathways are continuously shifting for a 7–10-day period [1]. This is when the brain is most vulnerable to repeated injuries.

Structural damage is also a concern. Recent studies have demonstrated cytoskeletal anchor points in the brain to be a primary target for neural injuries. Axons, especially unmyelinated, are more vulnerable to these types of injuries as well. Disruption with cytoskeletal components can lead to axonal disconnection in which neuronal axon connections are severed. In some cases, axonal disconnection is the result of atrophy or neuron shrinkage. Chronic axonal dysfunction can result in impaired cognitive function and slowed reaction time.

Changes with the glutamate NMDA receptor can lead to alterations in normal developmental plasticity, electrophysiology, and memory. These changes can also lead to immediate early gene activation and different calcium flux patterns. E/I balance is altered due to changes in inhibitory transmission with GABA and its receptors. Inflammation is caused by an increased activation of microglia and an upregulation of cytokines and inflammatory genes.

Figure 1. Neurometabolic cascade at the cellular level following a mild traumatic brain injury (mTBI).

 

Effects of Repeated Injury

There seems to be more extensive impairments following repeated mild TBI. There is little cell death observed after one mild TBI, but following a single moderate or severe TBI, cerebral and hippocampal degeneration and a loss of dopaminergic neurons in the substantia nigra is observed. DTI and MRI may be able to detect damage to cerebral networks, slowed conduction, and deficits in neurotransmission. DTI is better at detecting injuries of white matter by measuring where water diffusion is happening and in what direction within the brain. This measurement is referred to as fractional anisotropy [1].

The alterations that take place after an injury lead to the hallmark symptoms of concussions. Because of the energy crisis, the period after the injury and before the crisis subsides, the brain is especially vulnerable to repeated injuries. This can be what makes the healing process difficult to navigate. Since everyone’s situation is different, not allowing enough time for the brain to heal before returning to activity is common. This is dangerous because repeated injuries can lead to chronic traumatic encephalopathy, a condition involving aggregated tau proteins. These proteins are hallmarks of neurodegenerative diseases such as Alzheimer’s.

Allowing time for the brain to heal is the best treatment option to date. This poses an issue for athletes who are eager to return to play as soon as possible. It is important that people become educated on the risks of concussions and TBI and how they can lead to serious long-lasting effects and dysfunction if the proper precautions are not taken.

 

References

  1. Giza, C. C., & Hovda, D. A. (2014). The New Neurometabolic Cascade of Concussion. Neurosurgery, 75(Supplement 4), S24–S33. https://doi.org/10.1227/NEU.0000000000000505

Comorbidities With Mild Traumatic Brain Injuries

What is a mild traumatic brain injury and how do they happen?

Mild traumatic brain injuries (TBIs) are also referred to as concussions. They occur due to not only a bump or blow to the head, but also jolting the head too quickly. Essentially, the hit and movement of the head moves the brain too quickly. This causes chemical changes and stretching and damaging to brain cells. These are very serious injuries that may result in various symptoms [1]. Common symptoms of a concussion often mirror that of migraines including headaches, dizziness, nausea, and more. However, depending on the extent of the injury, it may result in cognitive and behavioral alterations [2].

What events take place in the brain after a mild TBI?

An article by Giza and Hovda discusses the fundamental neurometabolic cascade post-concussion (2014). The authors explain that the injury first begins with a potassium efflux, meaning it is leaving the cell, and sodium and calcium influx where these molecules flood into the cell. This triggers channels (voltage and ligand gated) to open and defuse through the rest of the cell. In an attempt to return to homeostasis, ATP membrane ionic pumps begin to work harder, and intracellular calcium is released, which furthers the energy crisis occurring in the cell because ATP is being utilized too much alongside mitochondrial dysfunction.

More specifically, intra-axonal calcium that is released to return the cell to homeostasis causes damage to neurofilaments and microtubules. This causes axonal dysfunction or even disconnection as these are two structures that are critical for structure and transportation within the axon. Each of these occurrences within the cell change ligand-gated excitatory and inhibitory neurotransmission, specifically for glutamate and GABA. Ultimately, downstream signaling and influx development is impacted causing vulnerability to comorbidities like anxiety disorders [2].

Common comorbidities

While neurological and psychiatric comorbidities are most commonly thought of due to the bodily region of the injury, others such as cardiovascular, endocrine, and respiratory can commonly occur as well. This makes sense because the brain is the control center for the rest of the body. Excitatory and inhibitory neurotransmission not only tells your body how to feel but also how to act. However, psychiatric comorbidities are among the most prevalent. Figure 1 displays the top 10 comorbidities seen in individuals as stated from a study by Sudhakar et al. (2023). The authors of this study explain how comorbidities are most likely to occur five years after the TBI has occurred with younger individuals (<50 years of age) being at increased risk for them [3].

Figure 1. Top 10 comorbidities with concussions [3].

Long term comorbidities and disorders

After repeated exposure to TBIs or more severe head injuries, long term neurological disorders may occur due to permanent damage in the brain such as cell death. Examples of these may include Chronic Traumatic Encephalopathy (CTE) which occurs after repeated head injuries which lead to a buildup of tau proteins, causing cognitive and behavioral changes. Another is Post-Concussion Syndrome (PCS) where the symptoms of the concussion last for an extended period of time. Interestingly, because of the connection of tau proteins, plaques, and cell death, risk for neurodegenerative diseases is also possible as the accumulation of brain damage may contribute to diseases such as Alzheimer’s. However, this proposition has yet to be studied further [4].

Tying it all together

Overall, mild TBIs are serious injuries that must be taken seriously. The neurometabolic cascade that occurs after them pose irregularities in excitatory and inhibitory neurotransmission that may contribute to different forms of comorbidities depending on where the brain is injured. This, as shown in figure 2, all comes together as the overall concussion symptoms that the individual faces. These comorbidities consist of psychiatric disorders such as depression and anxiety, cardiovascular comorbidities like hypertension, musculoskeletal, and more. Furthermore, even after the individual returns to normal activities, comorbidities may occur both short term and long term.

Figure 2. Conditions leading to overall concussion symptoms.

Fig.2. artstract created by M. Olson

Resources

[1] Mild TBI and Concussion | Concussion | Traumatic Brain Injury | CDC Injury Center. (2022, November 14). https://www.cdc.gov/traumaticbraininjury/concussion/index.html

[2] Giza, C. C., & Hovda, D. A. (2014). The New Neurometabolic Cascade of Concussion. Neurosurgery, 75(0 4), S24–S33. https://doi.org/10.1227/NEU.0000000000000505

[3] Sudhakar, S. K., Sridhar, S., Char, S., Pandya, K., & Mehta, K. (2023). Prevalence of comorbidities post mild traumatic brain injuries: A traumatic brain injury model systems study. Frontiers in Human Neuroscience, 17. https://doi.org/10.3389/fnhum.2023.1158483

[4] Madwire. (2023, September 21). Understanding the Link Between Concussions and Neurological Disorders. Atlanta Neuroscience Institute. https://atlneuroinstitute.org/blog/understanding-the-link-between-concussions-and-neurological-disorders/

Insulin and Alzheimer’s disease

A. The Pathway

I/ Insulin in the body

The insulin signaling pathway plays a crucial role in regulating glucose metabolism and energy homeostasis in the body. Key molecules involved in this pathway include insulin receptor (IR), insulin receptor substrate (IRS), phosphoinositide 3-kinase (PI3K), Akt (protein kinase B), and glycogen synthase kinase-3 (GSK-3).

In addition to its role in glucose metabolism, the insulin signaling pathway has been implicated in various cellular processes, including cell growth, proliferation, survival, and synaptic plasticity. Especially, in the brain, insulin signaling is particularly important for neuronal function and cognition, as insulin receptors in synaptic transmission and plasticity.

II/ Insulin and the brain

Recently, there is growing evidence suggesting that dysregulation of the insulin signaling pathway may contribute to neurodegeneration and Alzheimer’s disease (AD). For example, insulin resistance, characterized by impaired insulin signaling and reduced responsiveness to insulin, has been observed in the brains of individuals with AD. This insulin resistance may lead to dysfunction in glucose metabolism, energy deficits, oxidative stress, and impaired synaptic plasticity, all of which are implicated in the pathogenesis of AD.

Furthermore, abnormal activation of GSK-3, a downstream target of the insulin signaling pathway, has been linked to the hyperphosphorylation of tau protein and the formation of neurofibrillary tangles, a hallmark pathological feature of AD. Inhibition of GSK-3 has been proposed as a potential therapeutic strategy for AD.

B. Types and Treatments of AD

The National Institute on Aging (NIA) provides information on the treatment of Alzheimer’s disease (AD). Currently, there is no cure for AD, but various treatments can help manage symptoms and improve the quality of life for individuals with the condition. Treatment approaches include medication, lifestyle changes, and supportive therapies.

I/ Medications

    • Cholinesterase inhibitors: Drugs such as donepezil, rivastigmine, and galantamine may help improve cognitive symptoms by increasing levels of neurotransmitters involved in memory and learning.
    • Memantine: This medication regulates glutamate, a neurotransmitter involved in learning and memory, to help manage symptoms of moderate to severe AD.
    • Combination therapy: Some individuals may benefit from a combination of cholinesterase inhibitors and memantine.

II/ Supportive Therapies

      • Occupational therapy: Helps individuals maintain independence in daily activities.
      • Speech therapy: Assists with communication difficulties.
      • Physical exercise: Regular physical activity may help improve mood, sleep, and overall well-being.
      • Nutritional counseling: Ensures individuals receive adequate nutrition to support brain health.

III/ Clinical Trials

Participation in clinical trials for new medications and interventions is encouraged to advance research and potentially discover new treatments for AD.

IV/ Caregiver Support

Alzheimer’s often requires extensive caregiving, and support for caregivers is essential. Resources such as support groups, respite care, and educational programs can help caregivers manage stress and provide better care for their loved ones.

V/ Advance Planning

Individuals diagnosed with AD should engage in advance planning, including legal and financial arrangements and advance directives for healthcare decisions.

C. Future posibilities

Overall, the insulin signaling pathway plays a critical role in neuronal function and may represent a promising target for therapeutic intervention in neurodegenerative diseases such as Alzheimer’s disease. While current treatments cannot halt or reverse the progression of AD, they can help manage symptoms and improve quality of life for individuals with the condition. Further research is needed to elucidate the precise mechanisms linking insulin signaling dysfunction to neurodegeneration and to develop effective therapeutic strategies targeting this pathway.

Bibliography

Akhtar A, Sah SP. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer’s disease. Neurochem Int. 2020 May;135:104707. doi: 10.1016/j.neuint.2020.104707. Epub 2020 Feb 21. PMID: 32092326.

http://https://www.researchgate.net/publication/38070626_Insulin_is_a_Two-Edged_Knife_on_the_Brain

http://https://www.researchgate.net/publication/353826555_Role_of_DPP-4_and_SGLT2_Inhibitors_Connected_to_Alzheimer_Disease_in_Type_2_Diabetes_Mellitus

The Brain’s Response to Stressful Events

Picture 1: Stress and the Brain[1]

Most people face stressful situations often in their days, and we move on and go about our days. But what happens when we endure a psychologically stressful, traumatic event, how does that impact us and how does it impact our brain?

When you are exposed to long-term and chronic stress, this can lead to behavioral changes and changes in epigenetic regulation for gene transcription. When we are in traumatic or psychologically stressful situations we tend to form stronger memories, as it might be our bodies natural defense mechanism towards the event. However, creating stronger memories can also lead to the development of anxiety disorders like post-traumatic stress disorder (PTSD). PTSD is a disorder that can have serious comprimieses for the person’s quality of life over a long period of time, even lifelong. PTSD can develop as a result of damage and/or dysfunction of the dentate gyrus (DG) and other parts of the hippocampus[2]. About 10-20% of people who experience a traumatic event develops a stress-related disorders[3], such as PTSD.

Memory formation

We form memories because it allows us to interact in our environment, and to have the ability to build representations, understand and adapt to changes in the environment. In support of stronger memories being formed during stressful events, in hippocampus based behavioral models it was found that when we are exposed to a stressful event the stress-indices glucocorticoid hormones enhance the memory consolidation. The enhanced memory consolidation happens at the DG cellular level. Inputs from the hypothalamus and amygdala results in excitability of dentate neurons which can translate to an enhanced likelihood of NMDAR mediated activation of dentate granule neurons. This further leads to the activation of signaling, epigenetic, and changes within gene transcription that are all required for consolidation of memory[4]. Additionally, an important hormone is glucocorticoids, which are needed for memories associated with stressful challenges to be acquisitioned and consolidated.

What happens in the brain when a person is exposed to psychological stress?

When someone experiences psychological stress that activates the GR and NMDAR-ERK-MAPK pathways. GRs bind to intracellular receptors, and affects gene expression. The interaction of ERK1/2 and GR facilitates PERK1/2 to phosphorylate MSL1/2 and Elk-1. A result of this is the phosphorylation and acetylation of the histone dual mark H3S10p-K14ac, which allows genre transcriptions of the immediate early genes (IEGs), c-fos and erg1. These IEGs require the formation of H3S10p-K14ac in order to open up for transcription binding and the induction of gene transcription. This initiation of gene transcription is important for consolidation of memory formation with a traumatic or psychologically stressful event[5]. Figure 1, shows the signaling patway after exposure to psychological stress. So when a person is exposed to prolonged or psychological stressors there is an increased stimulation. And a factors that play a major role in modulating the effects of anxiety is GABA, which effects the responsiveness of dentate neurons to stressful events. GABA can be essential to prevent anxiety.

[6]

Figure 1: the psychological stress-activated signaling pathway that happens in the dentate gyrus, which modifies gene transcription, and consolidates memory formation and behavioral responses. 

Animal Models

The findings relating the pathways has been supported by animal models that study forced swimming induced behavioral immobility. The forced swimming test, rats or mice are put in a container that is filled with water and which they cannot stand in, testing how long the behavior of struggling and climbing movements appear, before an immobile or floating posture happens. Their immobility response is related to the NMDA-MEK-ERK-ELK/MSK pathway, and the phosphorylation. Alongside with GRs which in the DG are important for the consolidation of the behavioral response from the mice or rats.

Environmental factors

There has been suggestions that people who are more anxious are more likely or have an increased risk for developing PTSD after encountering a traumatic event[7]. Generally, feelings of anxiety are caused by environmental factors, and in relation to epigenetics, it shows how our behavior and environment cause changes in how the brain works. Which can be seen in the animal models and the study for forced swimming as this posed as an environmental challenge for the mice and rats. So, it might pose a question or suggestion that there might be genetic factors or implications that makes certain people more susceptible or vulnerable to develop PTSD? This topic would be interesting for further research.

 

Bibliography

[1] https://edrcsv.org/mercury-news-pandemic-stress-prematurely-aged-teens-brains-stanford-study-finds/

[2][3][4][5][6][7] Reul, J. M. H. M. (January 2014) Making memories of stressful events: a journey along epigenetic, gene transcription, and signaling pathways. Front Psychiatry, volume 5. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2014.00005/full

 

 

The Role of Memory Formation in Anxiety

Making memories is crucial for our learning and survival. Our memories are what make us who we are. They shape our personality. Emotional or stressful memories are better remembered than neutral experiences. Traumatic, emotional, and stressful experiences are linked to psychological disorders like anxiety, depression, and PTSD. According to an article published by the National Institutes of Health, a large number of studies have observed that increasing levels of stress is necessary for the formation of long-lasting memories that are stronger and more persistent than normal, neutral memories [2]. The question is, why is this the case? Why do stressful memories lead to stronger connections and how does that lead to psychological disorders? Responses to stressful events produce changes in the brain at the cellular level, leading to measurable changes in brain structure. These changes involve epigenetics, gene transcription, and signaling pathways.

Animal Models

One of the most common tests to measure memory consolidation is the forced swim test in which a mouse will be placed in a tub of water and the amount of time it takes for the mouse to move into an immobile, floating position is measured. What should happen is that when the mouse is reintroduced to the tub it spends less time struggling before moving into a floating position because it remembers that after a certain amount of time, it will be removed from the water.

Researchers observed that glucocorticoids are important for the strengthening of memories regarding a stressful situation. Interestingly, glucocorticoid receptor antagonists administered to only the dentate gyrus in mice produced a delay in the immobility response during the forced swim test.

Epigenetics

This research also prompted the finding of a dual histone mark in granule neurons in the dentate gyrus. This modification happened after experiencing a stressful or traumatic event. The glucocorticoid receptor antagonist also seemed to inhibit the increase of the dual histone mark in the DG neurons after the forced swim test.

The NMDA receptor mediated ERK-MAPK pathway is involved in learning and memory processes. Studies showed that a MEK inhibitor activated the increase of the histone mark, indicating that this pathway was somehow involved. Figure 1 shows a detailed pathway of how the histone mark leads to the upregulated transcription of immediate early genes like c-Fos and Egr-1.

To put it all together we can look at the image above. Stressful, or traumatic events initiate the activation of glucocorticoid receptors and the NMDAR-ERK-MAPK pathway. The activation of the specific molecule ERK1/2 and along with the glucocorticoid receptors activates nuclear kinases that are responsible for the dual histone mark. The formation of this histone mark allows chromatin to decondense and allow the transcription of the immediate early genes. These genes are needed for the consolidation of memory formation and when their expression is upregulated, the memory formation can happen too excessively [1].

Risk Factors and Treatment Options

This phenomenon is only observed in some people who experience a traumatic event or prolonged stress or abuse. Researchers believe that more anxious people are more likely to develop a stress related disorder due to the formation of stronger memories of stressful events. It is unclear why this is the case.

There have been pharmacological approaches studied to utilize the effects of GABAergic drugs since GABA plays a role in modulating anxiety. These drugs resulted in the blockage of the dual histone mark and may be a possible treatment option for anxiety or related disorders in the future. Long term exercise was also found to reduce feelings of anxiety. In some countries, exercise is even prescribed along with traditional pharmacological treatments.

 

References

  1. Dong, Y., Taylor, J. R., Wolf, M. E., & Shaham, Y. (2017). Circuit and Synaptic Plasticity Mechanisms of Drug Relapse. The Journal of Neuroscience, 37(45), 10867–10876. https://doi.org/10.1523/JNEUROSCI.1821-17.2017
  2. Reul, J. M. H. M. (2014). Making Memories of Stressful Events: A Journey Along Epigenetic, Gene Transcription, and Signaling Pathways. Frontiers in Psychiatry, 5. https://doi.org/10.3389/fpsyt.2014.00005

Understanding Addiction: Why It Matters and How We Can Make a Difference

 

 

Addiction is a pervasive issue that touches the lives of millions of people worldwide. Whether it’s substance abuse, such as alcohol or drugs, or behavioral addictions like gambling or gaming, the impact of addiction goes far beyond the individual struggling with it. As members of society, it is important for us to recognize the importance of understanding addiction and the role each of us can play in addressing this complex issue.

 

First and foremost, addiction is a public health concern. It affects individuals of all ages, races, and socioeconomic backgrounds, leading to devastating consequences for individuals, families, and communities. From health problems and financial instability to strained relationships and legal issues, the ripple effects of addiction are profound and far-reaching. By raising awareness about addiction, we can shed light on its prevalence and the urgent need for effective prevention, treatment, and support services.

 

 

 

 

When it comes to the science, Glutamate, particularly in the mesolimbic dopamine system, plays a significant role in mediating the rewarding effects of drugs. Drugs of abuse, such as cocaine, heroin, and alcohol, can increase the release of dopamine in the nucleus accumbens, a key part of the brain’s reward circuitry. Glutamate transmission from neurons in other brain regions, such as the prefrontal cortex and the amygdala, to the nucleus accumbens is critical for regulating dopamine release and reinforcing drug-seeking behavior.

 

Addiction is also linked to mental health. Many individuals struggling with addiction also battle co-occurring mental health disorders such as depression, anxiety, or trauma. Addressing addiction requires an approach that recognizes the relationship between mental health and substance abuse. By promoting mental health awareness and destigmatizing seeking help for mental health issues, we can create a more supportive environment for individuals seeking recovery from addiction.

 

Each of us has a role to play in addressing addiction within our communities. Education is a powerful tool in combating stigma and misinformation surrounding addiction. By learning about the science of addiction, including its neurobiological underpinnings and risk factors, we can foster empathy and understanding for those affected by addiction. Additionally, we can advocate for policies and resources that prioritize addiction prevention, early intervention, and access to evidence-based treatment options.

 

Furthermore, support and compassion are essential components of addiction recovery. As members of society, we can offer a helping hand to those struggling with addiction by providing non-judgmental support, encouragement, and access to resources. Whether it’s volunteering at a local recovery center, participating in community awareness events, or simply lending a listening ear to someone in need, small acts of kindness can make a significant difference in someone’s journey toward recovery.

 

 

Prevention is another key aspect of addressing addiction. By promoting healthy coping mechanisms, life skills, and resilience-building strategies, we can empower individuals to make positive choices and avoid the pitfalls of addiction. This includes providing education and support to young people, as well as promoting community-wide initiatives that reduce risk factors and promote protective factors against addiction.

In conclusion, addiction is a complex issue that requires a collective effort to address effectively. By raising awareness, promoting understanding, and offering support, each of us can contribute to creating a society where individuals affected by addiction are met with compassion, empathy, and access to the resources they need to heal and thrive. Together, we can make a difference in the lives of those impacted by addiction and build healthier, more resilient communities for all.

Artstract created by E.Phiri

 

 

“Glutamate Receptors and Drug Addiction.” Neuropathology of Drug Addictions and Substance Misuse, Academic Press, 29 Apr. 2016, www.sciencedirect.com/science/article/abs/pii/B978012800634400010X.

Volkow, Nora D., et al. “Neuroscience of Addiction: Relevance to Prevention and Treatment.” American Journal of Psychiatry, 25 Apr. 2018, ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.17101174.

NIDA. 2018, June 6. Understanding Drug Use and Addiction DrugFacts. Retrieved from https://nida.nih.gov/publications/drugfacts/understanding-drug-use-addiction on 2024, March 25

Melinda Smith, M. A. (2024, February 5). Understanding addiction. HelpGuide.org. https://www.helpguide.org/harvard/how-addiction-hijacks-the-brain.htm

Community Health Net. (2024, January 9). Substance abuse awareness: Breaking free from addiction together. https://www.community-healthnet.com/posts/substance-abuse-awareness-breaking-free-from-addiction-together/

 

From Stress to Strong Memories to PTSD: How stressful events form strong memories that can lead to anxiety disorders

Effects of Stress on Learning and Memory Processes

Psychologically stressful events evoke a long-term impact on behavior through changes in hippocampal function. These changes in glutamatergic, GABAergic, and glucocorticoid hormone signaling lead to altered regulation of gene transcription. Specifically, these epigenetic changes moderate the ERK/MAPK signaling pathway and the induction of c-fos and egr-1 genes.

Without memory, we could not function as human beings. We need memories to understand our environment and make decisions based on past knowledge. The hippocampus is an important brain region for memory formation. It’s vital for the consolidation of contextual memories. During stressful events, there is an increase in the secretion of glucocorticoid hormones (i.e. cortisol) that enhances memory formation in the hippocampus. The hypothalamus’s dentate gyrus (DG) is another important brain region involved in memory formation. The glucocorticoid receptors (GRs) in the dentate gyrus were found to be involved in the consolidation of adaptive responses based on memories of initial experiences.

In stressful events, we often form strong memories, however not all stressful events incapacitate people and keep them from their daily lives. So, why does 10% of the population develop PTSD? When people cannot adapt and cope after stressful events, they can develop an anxiety disorder like post-traumatic stress disorder (PTSD).

Figure 1. How stress affects our regulation of cortisol and impacts memory formation (3).

A Signaling Pathway Involved in Learning and Memory Processes

Calcium activates the NMDA receptor and mediates the ERK-MAPK signaling pathway. The activated ERK pathway helps form the dual histone marks in the DG granule neurons. When GRs are activated, they act like scaffold proteins for the ERK pathway), pERK1/2 then phosphorylates MSK1/2 and Elk-1. MSK phosphorylates serine (S10) and Elk-1 acetylates lysine (K14) of histone (H3) molecules within the c-fos and egr1 gene promoters. These modifications make histones less positive which causes DNA to unwind from them, allowing transcription factors to bind. Histone modifications and chromatin opening are needed to provide transcription factors access to their DNA binding sites.

Figure 2. Psychological stress-activated signaling pathways in dentate gyrus granule neurons drive epigenetic modifications underlying the induction of gene transcription and the consolidation of behavioral responses and memory formation in the hippocampus (1).

Epigenetics

Epigenetics is the study of how your behaviors and environment can cause changes that affect the way your genes work. Epigenetic changes that occur as a result of stressful events cause an increase in dual histone marks (H3S10p-K14ac). These dual histone marks are hypothesized to open chromatin’s structure by unraveling the histones from DNA so that transcription factors can bind to previously silent genes and IEG promoters. Immediate-early genes (IEGs) are crucial for memory formation, like c-fos and egr-1.

Nothing in Anxiety Disorders like PTSD makes sense, except in the light of stress-driven increases in dual histone marks and IEGs.

GABAergic Tone

The GABAergic system, known for its role in regulating anxiety states, influences the responsiveness of granule neurons in the DG to psychological stress. High anxiety levels are associated with low GABA activity, which can lead to debilitating effects. Balancing excitatory and inhibitory inputs is crucial for maintaining healthy information flow in brain circuits.

Figure 3. An imbalance of excitatory and inhibitory neurotransmission can lead to anxiety (2).

How do Strong Memories of Stressful Events Turn into PTSD?

When a stressful event overwhelms a person’s coping mechanisms, it can lead to the formation of strong memories. Overactive signaling pathways involving NMDARs, GRs, ERK/MAPK, MSK, and Elk-1 contribute to heightened stress responses and the consolidation of these memories. Higher levels of anxiety can further strengthen these memories and increase the likelihood of maladaptive responses to future stressful events.

Stressful situations have a profound impact on memory formation, often resulting in strong memories that can lead to anxiety disorders like PTSD. Understanding the intricate mechanisms involved, from epigenetic changes to neurotransmitter dynamics, is crucial for developing targeted interventions and therapies to support individuals affected by these conditions.

Figure 4. PTSD vs Anxiety (4).

References

[1]   J. M. H. M. Reul, “Making Memories of Stressful Events: A Journey Along Epigenetic, Gene Transcription, and Signaling Pathways,” Front. Psychiatry, vol. 5, 2014, doi: 10.3389/fpsyt.2014.00005.
[2]  “About GABA and Glutamate.” Accessed: Mar. 25, 2024. [Online]. Available: https://pmhealthnp.com/about-gaba-and-glutamate/
[3]  N. Srivastava, “How stress effects our memory,” Yoga Anatomy in Manchester a Revolution in Movement. Accessed: Mar. 25, 2024. [Online]. Available: https://www.yoga-anatomy.com/help-ive-forgot-stress-memory/
[4]  C. B. H. Staff, “Acute Stress Disorder vs PTSD: 3 Key Differences,” Compassion Behavioral Health. Accessed: Mar. 25, 2024. [Online]. Available: https://compassionbehavioralhealth.com/blog/acute-stress-disorder-vs-ptsd/

Addiction and the Brain

What is addiction?
Addiction is a dependence on a substance or certain activity like drugs, alcohol, gambling, and more. What characterizes a behavior as an addiction is that the person continues to take the substance or take part in the activity even though it negatively impacts daily life. Addiction has been found to be a brain disease in which the brain undergoes physical changes in its circuitry, so overcoming addiction is not as simple as it may have once seemed.

Figure 1. Cartoon visualization of brain circuitry. [1]

What does addiction look like in the brain?
The brain first receives information from a rewarding stimulus which is processed primarily in the hippocampus and the amygdala. The ventral tegmental area (VTA) is stimulated which releases dopamine and travels through the mesolimbic pathway to the nucleus accumbens (NAc). A reinforcement signal is then sent to the prefrontal cortex which associates the rewarding stimulus with the pleasure response in the NAc. The role of glutamate is important in the reward system because it regulates dopamine release to the NAc. The continued use of drugs or some other substance or activity makes this reward pathway stronger and the reward pathway takes over the individual’s brain and all attention goes to the drug or drug-related cues.

Figure 2. Dopaminergic and glutamatergic projections in the brain. [2]
Figure 3. Cartoon visualization of the reward pathway with dopaminergic and glutamatergic projections. [3]

Role of synaptic plasticity
Synaptic plasticity is the ability of the brain to change the strength of connections between neurons and is essential to the ability of the brain to learn and develop new memories. There are two types of long-term plasticity, long term depression (LTD) and long term potentiation (LTP), both of which occur in the hippocampus and are triggered by NMDA receptors. LTP refers to connections between neurons becoming stronger and LTD refers to the connections becoming weaker. Both are essential for the formation of memories. Synaptic strength is seen in the mesolimbic pathway in people with substance use disorder (SUD) in which the connections between neurons are becoming stronger and LTP has occurred. This is thought to be the reason behind relapse; people with addiction have these pathways being stronger, so it becomes more difficult for the brain to be rewarded by “normal” mechanisms like food, and it becomes much easier to fall back into the habit of taking the substance because those pathways are so prominent. [4]

Figure 4. Comparison of synaptic neurotransmission in a brain absent of drugs and a brain exposed to drugs. [5]

What does all of this mean?
The brain undergoes major circuitry changes after continuous use of substances which is what contributes to the symptoms of addiction. Someone who has developed an addiction to a certain substance will have a very difficult time overcoming their addiction because the brain has changed long-term and it takes an extensive amount of time to change it again. It is unknown whether or not the brain has the ability to change back to the way it was before addiction, but it seems unlikely that it would ever be the same. Those with addiction typically cannot take that certain substance again without relapsing, so it makes sense that LTP and LTD have long-lasting effects on the brain and it would not be able to return back to pre-drug condition.

Figure 5. Artstract of addiction and its overcoming quality by Kelly Pudwill

 

References
[1] Department of Health and Human Services. (October, 2015). Biology of Addiction. National Institute of Health. https://newsinhealth.nih.gov/2015/10/biology-addiction.
[2] Mozafari, R., Karimi-Haghighi, S., Fattahi, M., Kalivas, P., & Haghparast, A. (2022). A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder. Progress in Neuropsychopharmacology & Biological Psychiatry, 124. https://doi.org/10.1016/j.pnpbp.2023.110735.
[3] Su, Yun-Ai & Si, Tianmei. (2022). Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. General Psychiatry. 35. e100724. 10.1136/gpsych-2021-100724.
[4] Stampanoni Bassi, M., Iezzi, E., Gilio, L., Centonze, D., & Buttari, F. (2019). Synaptic Plasticity Shapes Brain Connectivity: Implications for Network Topology. International journal of molecular sciences, 20(24), 6193. https://doi.org/10.3390/ijms20246193.
[5] Niehaus, J.L., Cruz-Bermúdez, N.D., & Kauer, J.A. (2009). Plasticity of addiction: a mesolimbic dopamine short-circuit? The American journal on addictions, 18 4, 259-71. https://pubmed.ncbi.nlm.nih.gov/19444729/ .

The Road to Better Understanding the Impacts of Addiction in the Brain

Picture 1: Addiction affecting the brain. 

Addiction is a difficult disorder both mentally and physically for the individuals, but also for the people around them. Additionally, it has been found to have effect on structures within our brains. But what is addiction, or more specifically substance use disorder (SUD), it has been defined as “a drastic and chronic relapsing disorder characterized by difficulty in limiting drug intake, showing high motivation for drug use, and pursuing drug-taking despite negative emotional and physiological experiences”[1].

How does addiction affect the brain?

The reward circuits are a part of all the motivated behaviors that are related to both natural and drug reinforcers and are therefore this brain circuit plays a bigrole in addiction. Prolonged drug abuse causes dysregulated functional connectivity in the brain that alters receptor and transporter expression for monoamines and changes the strengths of the synapses (Figure 1). This leads to more frequent neurotransmitter synthesis and release in various part of the reward circuit[2]. These impairments contribute to the behavioral and cognitive impairments in people that suffer from addiction. There are several brain regions connected to the reward circuit, these include the ventral tegmental area (VTA) and the nucleus accumbens (NAc).

Glutamate is the most excitatory neurotransmitter in the central nervous system, as well as having a role in the brain regions that are connected to the reward circuit which makes glutamate a central neurotransmitter when understanding drug use disorders.

Figure 1: Synaptic plasticity, increase in neurotransmitter release and/or number of postsynaptic receptors available. 

The increase in catecholamines, primarily dopamine, leads to more neurotransmission that leads to synaptic plasticity. In relation to addiction the synaptic and memory theory plays a role in understanding the changes that happens within brain. Learning happens thought various synaptic mechanisms cause changes in the connection that happens between neurons[3]. When the synaptic mechanisms are changed, and the brain learns new ways to function as a response to the drug use, it changes the mechanism within the brain.

 

The role of empathy

Picture 2: showing empathy. 

After seeing the effects that drug abuse have on the brain, and the change in structures within the brain, can behaviors by individuals with these disorders be better understood? Empathy might play a significant role for people dealing with these disorders, and that coming from the people around them if its health professional or family members it can be crusical in recovery. There is a lot og negative stigma around drug use disoders, and that causes a lack of empathy, because it is hard to understand why an indivdual would pertain to certain behaviors. Looking into the physical changes in combinations of understanding why someone develop the disorder, can lead people to have more empathy for the individuals that are struggling with these disorders.

The causes of addiction can be many, such as comorbities, trauma, stress, etc., and the relation might give a better look into the development of drug use disorders. As for cormorbidities, mental health disorders and somatic disorders can play a role in why someone develop the disorders. Depression is the most prevalent for the mental health disorders that comorbid with drug use disorders[4], and these can be risk factors for developing the substance use disorders. In order to create a better understanding, and for people to improve their empathy for people with these disorders, might be the indivudals differences, and the background to why they developed the disorder.

Bibliography

[1] Mozafari, R., Karimi-Haghighi, S., Fattahi, M., Kalivas, P., & Haghparast, A. (2023). A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder. Progress in neuro-psychopharmacology & biological psychiatry124, 110735. https://doi.org/10.1016/j.pnpbp.2023.110735

[2] Mozafari, R., Karimi-Haghighi, S., Fattahi, M., Kalivas, P., & Haghparast, A. (2023). A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder. Progress in neuro-psychopharmacology & biological psychiatry124, 110735. https://doi.org/10.1016/j.pnpbp.2023.110735

[3] Mozafari, R., Karimi-Haghighi, S., Fattahi, M., Kalivas, P., & Haghparast, A. (2023). A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder. Progress in neuro-psychopharmacology & biological psychiatry124, 110735. https://doi.org/10.1016/j.pnpbp.2023.110735

[4] United Nations Office on Drugs and Crime (March, 2022) Comorbidities in drug use disorders. Commission on Narcotic Drugs, 65th session. Retrieved from https://www.unodc.org/documents/drug-prevention-and-treatment/UNODC_Comorbidities_in_drug_use_disorders.pdf on 2024, March 12

Psychostimulants Change Our Brain

Addiction

Artstract. Art found online that I believe depicts the detrimental impact psychostimulant drug use has on our brains.

Psychostimulant Use Disorder

Psychostimulant Use Disorder (PUD) causes changes in the brain’s reward circuit and glutamatergic neurotransmission. Because amphetamine-like psychostimulants have a similar structure (phenylalkylamines) to the endogenous catecholamine neurotransmitters (norepinephrine, epinephrine, and dopamine), psychostimulants are theorized to alter catecholamine neurotransmission. These changes lead to dopamine-driven reinforcement and drug-seeking behaviors (1).

Nothing in PUD makes sense, except in the light of altered brain neuroplasticity.

 

Figure 1. Psychostimulant structure compared to catecholamine neurotransmitters (2).

Psychostimulants

Psychostimulants are drugs that increase (“stimulate”) the CNS. They bind to extracellular catecholamine receptors (i.e. DA) to promote the release of neurotransmitters (NTs). They can also suppress monoamine NT reuptake and oxidase metabolism, which leads to elevated levels of NTs in the synapse.

Glutamate

Glutamate is the primary excitatory neurotransmitter in the central nervous system. Modulating glutamate neurotransmission has emerged as a promising approach for treating cognitive deficits associated with substance use disorders (SUDs), including PUD. When glutamate is released from presynaptic neurons, it diffuses through the synapse and binds to various glutamate receptors including ionotropic (such as NMDA and AMPA) receptors that are fast-acting and crucial for brain plasticity as well as metabotropic receptors. Metabotropic glutamate receptors are categorized into three groups:

Group 1

  • mGluR1 & mGluR5
  • postsynaptic
  • Gq-coupled.

Group 2

  • mGluR2 & mGluR3
  • presynaptic
  • Gi-coupled.

Group 3

  • mGluR4 & mGluR6 & mGluR7 & mGluR8
  • presynaptic
  • Gi-coupled.

Figure 2. Distribution of mGluRs in the Brain’s Reward Circuit (1).

Neurocircuitry of SUDs: The Brain’s Reward Circuit

The reward circuit involves intricate interactions between dopaminergic projections from the ventral tegmental area (VTA), glutamatergic and GABAergic neurotransmission, and brain regions like the medial prefrontal cortex (mPFC) and nucleus accumbens (NAc).

Dopamine activity in the brain is modulated by the VTA brain region. In reward processing and drug-seeking behaviors, glutamatergic neurons from the mPFC stimulate the VTA’s dopaminergic neurons to release dopamine in the NAc (1).

Figure 3. VTA plays an important role in the brain’s reward circuit (3).

Neuroplasticity and Memory Formation in PUD:

Alterations in synaptic strength, dendritic morphology, and receptor expressions are found in neurons associated with the brain’s reward circuits. Long-term potentiation (LTP) and long-term depression (LTD) in glutamate synapses, particularly in the hippocampus and mesocorticolimbic pathways play a crucial role in the altered neuroplasticity that comes from drug abuse.

Group 1 mGluRs have been found to affect synaptic plasticity in reward circuit brain regions in PUD cases. They modulate short- and long-term synaptic plasticity, including LTD, through intracellular signaling pathways involving phospholipase C (PLC) that increase learning, memory, and LTP. mGluR1 is thought to be involved in the acquisition process while mGluR5 has a role in retaining and maintaining spatial memories. Because group 1 mGluRs are located on the postsynaptic neuron, antagonist drug treatments have been found to reduce drug-seeking behaviors by blocking the reward signal from being passed on (1).

Figure 4. Antagonist drug treatments have been found to reduce addiction when targeting Group 1 receptors because they inhibit mGluRs on the postsynaptic cell.

Group 2 mGluRs negatively regulate glutamate release and are necessary for inducing LTD in the reward circuit. Because group 2 mGluRs are located on the presynaptic neuron, agonist drug treatments have been found to reduce drug-seeking behaviors by stimulating auto receptors to decrease the number of neurotransmitters released in the synapse (1). Group 3 mGluR’s role in PUD synaptic plasticity needs to be studied further, particularly mGluR7 and 8 in regions like the NAc, VP (striatum), and the hypothalamus.

Figure 5. Agonist drug treatments have been found to reduce addiction when targeting Group 2 receptors because they stimulate the mGluR auto receptors that self-regulate by reducing NT release.

Questions to Think About…

  • Does the altered brain chemistry from addiction ever go back to the way it was?
  • Can we unlearn memory/ the motivated driver of addiction?

 

 

References

[1]    R. Mozafari, S. Karimi-Haghighi, M. Fattahi, P. Kalivas, and A. Haghparast, “A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 124, p. 110735, Jun. 2023, doi: 10.1016/j.pnpbp.2023.110735.
[2]   “Figure 1. Structural image of catecholamines and drugs of abuse known…,” ResearchGate. Accessed: Mar. 20, 2024. [Online]. Available: https://www.researchgate.net/figure/Structural-image-of-catecholamines-and-drugs-of-abuse-known-to-contribute-to-cardiac_fig5_254259828
[3]   “Figure 1. Intrinsic and extrinsic circuitry of the ventral tegmental…,” ResearchGate. Accessed: Mar. 20, 2024. [Online]. Available: https://www.researchgate.net/figure/Intrinsic-and-extrinsic-circuitry-of-the-ventral-tegmental-area-VTA-VTA-dopamine_fig1_51922788

Spam prevention powered by Akismet